| Date | Title | Description | Source |
| 25.04.2024 | Cerevance Secures $47M to Drive Innovation in CNS Therapeuti... | Cerevance, a Boston-based company specializing in precision treatments for central nervous system (C... | parsers.vc... |
| 25.04.2024 | Cerevance Adds $47 Million in Series B-1 Extension to Advanc... | - | globenewsw... |
| 25.04.2024 | Cerevance Raises $47M in Series B-1 Extension | Cerevance, a Boston, MA-based company focused on developing precision novel therapeutics for central... | finsmes.co... |
| 25.04.2024 | Cerevance Adds $47 Million in Series B-1 Extension to Advanc... | Financing round led by Agent Capital, Bioluminescence, and Double Point Ventures, with participation... | einpresswi... |
| 13.03.2024 | Cerevance Announces Presentation at Alzheimer’s Research UK ... | - | globenewsw... |
| 13.02.2023 | Cerevance Expands Series B Financing with Additional $51 Mil... | - | globenewsw... |
| 13.02.2023 | Cerevance Closes $51 M with Series B Expansion |
BOSTON, MA, Cerevance, a private, clinical-stage drug discovery and development company
expands Se... | vcnewsdail... |
| 13.02.2023 | Cerevance expands financing bringing the total Series B fina... | - | dolbyventu... |
| 13.02.2023 | Cerevance Expands Series B Financing with Additional $51 Mil... | Proceeds will advance Cerevance’s potential first-in-class programs developed using proprietary NETS... | svhealthin... |
| 13.02.2023 | Cerevance Expands Series B Financing with Additional $51M | Cerevance, a Boston, MA-based private, clinical-stage drug discovery and development company, announ... | finsmes.co... |
| 23.01.2023 | Startups measuring the brain that you need to know | Companies are using biomarkers to diagnose and treat mental illness and other neurological disorders... | vator.tv/n... |
| 22.07.2020 | Excellent news today from our portfolio company @Cerevance o... | The additional proceeds will aid in the development of the company’s NETSseq platform which it is us... | svhealthin... |
| 21.07.2020 | Cerevance Expands Series B Financing to $65M | BOSTON, July 21, 2020 (GLOBE NEWSWIRE) -- Cerevance, a private drug discovery and development compan... | citybizlis... |
| 21.07.2020 | Foresite Capital Joins $65M Series B Financing for Cerevance | BOSTON, July 21, 2020 (GLOBE NEWSWIRE) -- Cerevance, a private drug discovery and development compan... | citybizlis... |
| 21.07.2020 | UPMC Enterprises Joins $65M Series B Financing for Cerevance | BOSTON, July 21, 2020 (GLOBE NEWSWIRE) -- Cerevance, a private drug discovery and development compan... | citybizlis... |
| 17.04.2020 | RDMD raises $14M for rare disease real-world evidence genera... | The company said Thursday that it had raised the money in an equity financing round led by PSP Inves... | medcitynew... |
| 16.04.2020 | Daily funding roundup - April 15th, 2020 | AI.Reverie raised $5.6M; Atlas AI landed $7M; Nelumbo secured $14M; Perspectum picks up $36M
AI.Reve... | vator.tv/n... |
| 14.04.2020 | Cerevance Closes $45M Series B Financing | BOSTON, MA, April 14, 2020 (GLOBE NEWSWIRE) -- Cerevance, a private drug discovery and development c... | citybizlis... |
| 14.04.2020 | Cerevance Closes $45 Million Series B Financing - proceeds t... | Cerevance will use the proceeds of the financing to continue identifying novel therapeutic targets f... | svhealthin... |
| 14.04.2020 | Touting new way of mining neuro targets, Takeda spinou... | More than three years after Takeda spun out its top neuroscience team in Cambridge, UK into a ... | endpts.com... |
| 26.06.2019 | It’s time to find new targets for brain diseases instead of ... | I first learned about drug discovery and development in the mid-1990s when two of my sons were diagn... | statnews.c... |
| 29.09.2017 | Pfizer spin-off SpringWorks embraces shelved therapies | Sometimes science is an uncooperative friend that doesn’t play nice with corporate strategies. Promi... | medcitynew... |
| 03.05.2017 | DDF to Invest $5 Million in Cerevance to Seek New Treatments... | Dementia Discovery Fund to Invest $5 Million in Cerevance to Seek New Treatments for Dementia | svhealthin... |
| 03.05.2017 | Term Sheet — Wednesday, May 3 | GOING GREEN
Hello from New Orleans, where I’m in town for the Collision conference. Yesterday I inte... | fortune.co... |
| 03.05.2017 | Dementia Discovery Fund to Invest $5 Million in Cerevance | LONDON & BOSTON--(BUSINESS WIRE)--The Dementia Discovery Fund, an innovative global investment f... | citybizlis... |
| 03.05.2017 | Cerevance Raises $5m in Equity Funding | Cerevance, a Boston, Massachusetts and Cambridge, UK-based drug discovery startup, raised $5m in equ... | finsmes.co... |
| 06.12.2016 | Cerevance Raises $36M Funding from Lightstone Ventures | OSAKA, Japan & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Takeda Pharmaceutical Company Limited (TOKYO:4... | citybizlis... |
| 06.12.2016 | Cerevance Raises $36M | Cerevance, a Cambridge, MA-based neuroscience company, raised $21.5m in Series A financing.
Founding... | finsmes.co... |
| - | Cerevance | “Home - Cerevance” | fastfounde... |
| - | Pfizer spin-off SpringWorks embraces shelved therapies | Pfizer spin-off SpringWorks Therapeutics is carving out a niche repurposing useful molecules from mo... | medcitynew... |
| - | RDMD raises $14M for rare disease real-world evidence genera... | Despite the ongoing Covid-19 pandemic, many startup companies are continuing to close funding rounds... | medcitynew... |
| - | Investors have poured $548 million into neuroscience biotech... | Peter Anastasiou, the CEO of Capsida Biotherapeutics. Capsida Biotherapeutics This story is availabl... | businessin... |
